Cardio-oncology in China.

Cardio-oncology China Evolvement of cardio-oncology Knowledge Transfer Model Multidisciplinary team

Journal

Current treatment options in oncology
ISSN: 1534-6277
Titre abrégé: Curr Treat Options Oncol
Pays: United States
ID NLM: 100900946

Informations de publication

Date de publication:
10 2023
Historique:
accepted: 10 07 2023
medline: 4 10 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Cardio-oncology is going under rapid development in various areas across an increasing number of provinces in China. However there are still a myriad of challenges that need to be overcome in order to ensure its gradual and consistent expansion. The Cardio-Oncology Knowledge Transfer Model (KTM) forms the basis to allow exponential development of effective cardio-oncology services. This would ensure the implementation of precision-based practice while dynamically evolving cardio-oncology to integrate both Western and Chinese medical practices to become an official clinical sub-speciality in its own right in China, for the ultimate benefit of the patient.

Identifiants

pubmed: 37566213
doi: 10.1007/s11864-023-01123-x
pii: 10.1007/s11864-023-01123-x
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1472-1488

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

K Sharma (K)

CardioOncology (Official Cardio-Oncology Organization in China), 201, Floor 2, Building B, The Rainbow Centre, Hongqiao, Hechuan Road 3051, Minhang District, Shanghai, 201100, China. kay@sanmed.cn.

Shanshan Wang (S)

CardioOncology (Official Cardio-Oncology Organization in China), 201, Floor 2, Building B, The Rainbow Centre, Hongqiao, Hechuan Road 3051, Minhang District, Shanghai, 201100, China.

Ying Liu (Y)

Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, 193 United Road, Dalian, 116021, Liaoning Province, China.

Yangli Zhang (Y)

Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, 193 United Road, Dalian, 116021, Liaoning Province, China.

Tong Liu (T)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, No. 23, Pingjiang Road, Hexi District, Tianjin, 300211, China.

Qingling Zhang (Q)

Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, No. 23, Pingjiang Road, Hexi District, Tianjin, 300211, China.

Qiaoqing Zhong (Q)

Department of Anesthesia, Critical Care & Pain Medicine Department, Beth Israel Deaconess Medical Center, Harvard Medical School, MA, 02215, Boston, USA.
Department of Cardiovascular Medicine, Xiangya Hospital, Central South University, 410008, Changsha, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH